Total Payments
$1,964
2024 Payments
$699.98
Companies
16
Transactions
87
Medicare Patients
229
Medicare Billing
$24,245
Payment Breakdown by Category
Food & Beverage$1,964 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,964 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $474.97 | 24 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $341.64 | 17 | $0 (2021) |
| Janssen Biotech, Inc. | $247.74 | 11 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $192.85 | 9 | $0 (2019) |
| QOL Medical, LLC | $138.27 | 5 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $120.93 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $107.61 | 4 | $0 (2024) |
| GENZYME CORPORATION | $94.65 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $68.01 | 3 | $0 (2024) |
| Endogastric Solutions, Inc | $44.04 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $699.98 | 33 | ABBVIE INC. ($210.66) |
| 2023 | $102.06 | 5 | Janssen Biotech, Inc. ($48.96) |
| 2022 | $127.24 | 3 | ABBVIE INC. ($100.72) |
| 2021 | $253.68 | 9 | Janssen Scientific Affairs, LLC ($101.94) |
| 2020 | $404.09 | 21 | Mallinckrodt Hospital Products Inc. ($283.95) |
| 2019 | $193.81 | 9 | Mallinckrodt Enterprises LLC ($76.87) |
| 2018 | $160.02 | 6 | Mallinckrodt LLC ($115.98) |
| 2017 | $23.35 | 1 | AstraZeneca Pharmaceuticals LP ($23.35) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $35.87 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Immunology | ||||||
| 10/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: VIROLOGY | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/26/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.37 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Immunology | ||||||
| 08/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: VIROLOGY | ||||||
| 07/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Immunology | ||||||
| 07/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $32.86 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: VIROLOGY | ||||||
| 06/28/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.55 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Immunology | ||||||
| 06/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.29 | General |
| Category: Immunology | ||||||
| 06/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Immunology | ||||||
| 06/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: VIROLOGY | ||||||
| 06/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: VIROLOGY | ||||||
| 05/31/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: VIROLOGY | ||||||
| 05/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Immunology | ||||||
| 04/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: VIROLOGY | ||||||
| 04/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 148 | 163 | $54,095 | $13,655 |
| 2022 | 3 | 81 | 99 | $22,125 | $10,590 |
Total Patients
229
Total Services
262
Medicare Billing
$24,245
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $8,440 | $3,102 | 36.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 13 | $9,810 | $2,586 | 26.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 28 | $3,360 | $1,699 | 50.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 20 | $5,960 | $1,283 | 21.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $11,726 | $1,166 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 16 | $2,007 | $1,144 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 19 | $1,520 | $963.11 | 63.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $6,556 | $857.82 | 13.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $4,716 | $852.97 | 18.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 38 | $12,350 | $5,736 | 46.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 45 | $6,975 | $3,506 | 50.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $2,800 | $1,349 | 48.2% |
About Dr. Aslam Syed, M.D
Dr. Aslam Syed, M.D is a Gastroenterology healthcare provider based in Chillicothe, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1487097481.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aslam Syed, M.D has received a total of $1,964 in payments from pharmaceutical and medical device companies, with $699.98 received in 2024. These payments were reported across 87 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,964).
As a Medicare-enrolled provider, Syed has provided services to 229 Medicare beneficiaries, totaling 262 services with total Medicare billing of $24,245. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Chillicothe, OH
- Active Since 04/10/2013
- Last Updated 09/13/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487097481
Products in Payments
- ACTHAR (Biological) $534.49
- MAVYRET (Drug) $277.87
- STELARA (Biological) $197.80
- DUPIXENT (Biological) $162.66
- SUCRAID (Drug) $138.27
- TREMFYA (Drug) $121.91
- ENTYVIO (Biological) $107.61
- CREON (Drug) $74.25
- HUMIRA (Biological) $49.23
- REMICADE (Biological) $48.96
- ESOPHYX (Device) $44.04
- Mavyret (Drug) $35.78
- IBSRELA (Drug) $29.54
- Mulpleta (Drug) $26.91
- RINVOQ (Biological) $26.47
- Bylvay (Drug) $18.99
- OverStitch Endoscopic Suturing System (Device) $18.49
- XIFAXAN (Drug) $16.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.